AI-Enhanced Insulin Pump System for Type 1 Diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Type 1 Diabetes diagnosis for at least one year
- Currently using an automated insulin delivery system (like a pump with automatic features)
- Willing to switch to a specific insulin type (lispro or aspart) during the study
- Have a trusted companion living with you or nearby who can help in emergencies
- Access to internet at home to upload device data regularly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Hear when a new Type 1 Diabetes Mellitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.